Higher mortality in postmenopausal women with RA and anti-CCP antibodies Science Daily (press release) Dec. 23, 2013 — New research shows mortality rates are two times higher in postmenopausal women with rheumatoid arthritis (RA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies. Findings published in the American College of Rheumatology ... |
